Astellas Pharma Inc. - Free Cash Flow To The Firm

Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Free-Cash-Flow-To-The-Firm" stands at 378.54 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.

Astellas Pharma Inc.'s second quarter result of 217.81 Billion JPY for the item "Free Cash Flow To The Firm" represents an increase of 364.63 percent compared to it's first quarter result.

Also, Astellas Pharma Inc.'s second quarter result of 217.81 Billion JPY for the item "Free Cash Flow To The Firm" represents an increase of 292.18 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Astellas Pharma Inc.'s second quarter result of 378.54 Billion JPY for the item "Free Cash Flow To The Firm" represents an increase of 75.03 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 150.36 percent compared to the value the year prior.
The 1 year change in percent is 150.36.
The 3 year change in percent is 94.61.
The 5 year change in percent is 154.76.
The 10 year change in percent is 259.02.

The Serie's long term average value is 174.37 Billion Japanese Yens. It's latest available value, on 09/30/2025, is 117.08 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2013, to it's latest available value, on 09/30/2025, is +67,316.54%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.